2025 Annual Meeting | C105 - Wake Up to Daytime Sleepiness: New and Emerging Concepts in the Diagnosis and Treatment of Hypersomnia Disorders

Date Monday 04/07/25

Time 11:15 AM - 12:15 PM PDT Add To Calendar

Location San Diego Convention Center | 10

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Nancy R. Foldvary-Schaefer, DO, FAAN

Topic(s) Sleep

Learning Objectives Participants should be able to identify the extensive burden of excessive daytime sleepiness and learn to differentiate hypersomnia disorders using the clinical history and evidence-based tools; know the data on sleep laboratory testing in narcolepsy, idiopathic hypersomnia, and other hypersomnia disorders and the pitfalls and limitations of the multiple sleep latency test in these populations; review the evidence for alerting medications for primary hypersomnia disorders and neurological disorders featuring hypersomnia as a key component and analyze the safety and efficacy of new and emerging therapies with unique mechanisms of action; and recognize the quality of life, functional and clinical impact of hypersomnia disorders and their comorbidities to strengthen dialogues with patients, families, and caregivers.

CME Available 1.00 CME credit

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
11:15 AM - 11:20 AM PDT	Introduction	Introduction Nancy R. Foldvary-Schaefer, DO, FAAN
11:20 AM - 11:45 AM PDT	Speaker	Evolution in Phenotyping of Primary CNS Hypersomnias and Diagnostic Testing Nancy R. Foldvary-Schaefer, DO, FAAN
11:45 AM - 12:05 PM PDT	Speaker	New and Emerging Therapies for CNS Hypersomnias and Implications of Comorbidities Sikawat Thanaviratananich, MD
12:05 PM - 12:15 PM PDT	Q&A	Questions and Answers Nancy R. Foldvary-Schaefer, DO, FAAN

Faculty Disclosures
Nancy R. Foldvary-Schaefer, DO, FAAN	Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Sikawat Thanaviratananich, MD	Dr. Thanaviratananich has nothing to disclose.

��ɫ��

��ɫ��